Morningstar Investment Services’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,389
Closed -$541K 227
2024
Q3
$541K Buy
25,389
+418
+2% +$8.23K 0.01% 267
2024
Q2
$479K Sell
24,971
-304
-1% -$6.2K 0.01% 258
2024
Q1
$489K Buy
25,275
+4,546
+22% +$90.1K 0.01% 235
2023
Q4
$434K Buy
20,729
+10,584
+104% +$203K ﹤0.01% 303
2023
Q3
$220K Buy
10,145
+612
+6% +$14.9K ﹤0.01% 267
2023
Q2
$224K Buy
+9,533
New +$219K ﹤0.01% 238
2022
Q3
Sell
-8,142
Closed -$204K 225
2022
Q2
$204K Buy
8,142
+1,719
+27% +$51.4K ﹤0.01% 215
2022
Q1
$216K Buy
+6,423
New +$211K ﹤0.01% 224

Other funds holding FMS

Morningstar Investment Services's FMS Position: Q4 2024 in Review

Morningstar Investment Services sold out of Fresenius Medical Care (FMS) in Q4 2024, closing a stake of 25,389 shares — an estimated $541K sold.

Morningstar Investment Services first reported a position in FMS in Q1 2022 and held it in 8 quarters. The position peaked at $541K in Q3 2024. 190 funds tracked by Wall St. Rank hold FMS as of Q4 2024.

  • Morningstar Investment Services reported no remaining Fresenius Medical Care position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 25,389 Fresenius Medical Care shares in Q4 2024, an estimated $541K.
  • Morningstar Investment Services first reported a position in Fresenius Medical Care in Q1 2022 and held it in 8 quarters.
  • Morningstar Investment Services's Fresenius Medical Care position peaked at $541K in Q3 2024.
  • 190 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.